Lee JC - Search Results

1

Control of microglial neurotoxicity by the fractalkine receptor.

Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. Cardona AE, et al. Among authors: lee jc. Nat Neurosci. 2006 Jul;9(7):917-24. doi: 10.1038/nn1715. Epub 2006 Jun 18. Nat Neurosci. 2006. PMID: 16732273

2

Differential roles of microglia and monocytes in the inflamed central nervous system.

Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, Lee JC, Taylor SE, Uehlein L, Dixon D, Gu J, Floruta CM, Zhu M, Charo IF, Weiner HL, Ransohoff RM. Yamasaki R, et al. Among authors: lee jc. J Exp Med. 2014 Jul 28;211(8):1533-49. doi: 10.1084/jem.20132477. Epub 2014 Jul 7. J Exp Med. 2014. PMID: 25002752 Free PMC article.

3

Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cells.

Kivisäkk P, Cotleur AC, Lee JC, Rudick RA, Ransohoff RM. Kivisäkk P, et al. Among authors: lee jc. J Neuroimmunol. 2003 Aug;141(1-2):150-4. doi: 10.1016/s0165-5728(03)00247-9. J Neuroimmunol. 2003. PMID: 12965266 Clinical Trial.

4

Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals.

Kivisäkk P, Trebst C, Lee JC, Tucky BH, Rudick RA, Campbell JJ, Ransohoff RM. Kivisäkk P, et al. Among authors: lee jc. J Neurovirol. 2003 Jun;9(3):291-9. doi: 10.1080/13550280390201001. J Neurovirol. 2003. PMID: 12775413

5

Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.

Rani MR, Xu Y, Lee JC, Shrock J, Josyula A, Schlaak J, Chakraborthy S, Ja N, Ransohoff RM, Rudick RA. Rani MR, et al. Among authors: lee jc. Ann N Y Acad Sci. 2009 Dec;1182:58-68. doi: 10.1111/j.1749-6632.2009.05068.x. Ann N Y Acad Sci. 2009. PMID: 20074275 Free PMC article.

6

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, Chang A, Ransohoff RM, Fisher E. Moll NM, et al. Among authors: lee jc. Ann Neurol. 2011 Nov;70(5):764-73. doi: 10.1002/ana.22521. Ann Neurol. 2011. PMID: 22162059 Free PMC article.

7

Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.

Fox RJ, Kivisakk P, Fisher E, Tucky B, Lee JC, Rudick RA, Ransohoff RM. Fox RJ, et al. Among authors: lee jc. Mult Scler. 2008 Sep;14(8):1036-43. doi: 10.1177/1352458508092261. Epub 2008 Aug 13. Mult Scler. 2008. PMID: 18701575

8

Defining interferon beta response status in multiple sclerosis patients.

Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Rudick RA, et al. Among authors: lee jc. Ann Neurol. 2004 Oct;56(4):548-55. doi: 10.1002/ana.20224. Ann Neurol. 2004. PMID: 15389896 Clinical Trial.

9

Chemokine receptors as biomarkers in multiple sclerosis.

Fox RJ, Kivisäkk P, Lee JC, Tucky B, Lucchinetti C, Rudick RA, Ransohoff RM. Fox RJ, et al. Among authors: lee jc. Dis Markers. 2006;22(4):227-33. doi: 10.1155/2006/694283. Dis Markers. 2006. PMID: 17124344 Free PMC article.

10

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis.

Rudick RA, Rani MR, Xu Y, Lee JC, Na J, Shrock J, Josyula A, Fisher E, Ransohoff RM. Rudick RA, et al. Among authors: lee jc. PLoS One. 2011;6(5):e19262. doi: 10.1371/journal.pone.0019262. Epub 2011 May 13. PLoS One. 2011. PMID: 21602934 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,830 results

Search Page